home / stock / kros / kros news

KROS News and Press, Keros Therapeutics Inc. From 08/13/20

Stock Information
Company Name: Keros Therapeutics Inc.
Stock Symbol: KROS
Market: NASDAQ
Website: kerostx.com
Menu
KROS KROS Quote KROS Short KROS News KROS Articles KROS Message Board
Get KROS Alerts

News, Short Squeeze, Breakout and More Instantly...
KROS - Keros Therapeutics EPS beats by $0.06

Keros Therapeutics (NASDAQ: KROS ) : Q2 GAAP EPS of -$0.62 beats by $0.06 . cash and cash equivalents of $144.7M. Press Release More news on: Keros Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,

KROS - Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results

LEXINGTON, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and muscu...

KROS - Keros Therapeutics to be Featured on The Balancing Act's "Behind the Mystery" Rare Disease Series

LEXINGTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients sufferi...

KROS - Keros Therapeutics, Inc. Announces Completion of Dosing of Planned Cohorts in KER-047 Phase 1 Trial and Provides Program Update

LEXINGTON, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients sufferi...
Previous 10 Next 10